IP Library › Patent Application 11557631
Patent Application
App. No. 11/557,631

SUCCINIMIDE AND MALEIMIDE DERIVATIVES AND THEIR USE AS TOPOISOMERASE II CATALYTIC INHIBITORS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/557,631
Abstract

Maleimide and succinimide derivatives were found to be effective topoisomerase II catalytic inhibitors. Due to this property, the maleimide and succinimide derivatives were investigated for their use as cytostatic agents and thus in the treatment of cancer. The compounds of the invention can be used in combination treatments with other cytostatic agents, such as topoisomerase II poisons. The maleimide and succinimide derivatives, due to their effective topoisomerase II catalytic inhibitory activity, are also useful as extravasation agents, such as upon administration of a topoisomerase II poison.

Claims (3)

1 - 47 . (canceled)

48 . A method for treating accidental extravasation, comprising (a) monitoring a subject for symptoms of extravasation after said subject has received a topoisomerase II poison and then, on the basis of said symptoms, (b) administering a catalytic topoisomerase inhibitor of formula M to said subject in an amount effective to counteract at least one of said symptoms.

49 . A method according to claim 48 , wherein said symptoms include ulceration in a region of said patient's body and step (b) comprises administering said inhibitor to said region.